The acquisition of Apogee Therapeutics, funded by this massive debt offering, will trigger a large-scale integration of all business functions, including IT systems, data platforms, and personnel.
Filing excerpt
The net proceeds from the sale of the Notes, after deducting the underwriting discounts and estimated offering expenses, are expected to be approximately $9.93 billion.
What this signalsFilings often name leadership changes, deals and spending plans.
Vendors
Vendors named
sec-8krestructuringGet every 8-K signal for AbbVie and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/f3c79264-a7d3-40de-a66c-994ef2b894d2 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.
{
"signal_id": "f3c79264-a7d3-40de-a66c-994ef2b894d2",
"signal_type": "sec-8k",
"signal_subtype": "restructuring",
"detected_at": "2026-08-11T08:05:03.463+00:00",
"company": {
"name": "AbbVie",
"domain": "abbvie.com"
},
"data": {
"detail": "The acquisition of Apogee Therapeutics, funded by this massive debt offering, will trigger a large-scale integration of all business functions, including IT systems, data platforms, and personnel. This creates immediate opportunities for vendors specializing in post-merger integration, system consolidation, and change management.",
"metrics": {
"timeframe": "immediate",
"dollar_context": "Net proceeds from debt offering to fund the acquisition of Apogee Therapeutics, Inc.",
"dollar_millions": 9930
},
"summary": "AbbVie raises $9.93B in debt to fund acquisition of Apogee Therapeutics, signaling major integration.",
"excerpts": "The net proceeds from the sale of the Notes, after deducting the underwriting discounts and estimated offering expenses, are expected to be approximately $9.93 billion.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465926091269/tm2621452d4_8k.htm",
"filing_date": "2026-08-05",
"filing_year": 2026,
"sales_relevance": "Change management needs",
"signal_category": "workforce",
"vendors_mentioned": [
"Morgan Stanley & Co. LLC",
"BofA Securities, Inc.",
"J.P. Morgan Securities LLC",
"SG Americas Securities, LLC"
]
}
}
curl https://signals.autobound.ai/v1/signals/f3c79264-a7d3-40de-a66c-994ef2b894d2 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"abbvie.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.